NF-κB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 42, 2010, Pages 18061-18066

  Busuttil, Valere ^a   Droin, Nathalie ^a,b   McCormick, Laura ^a   Bernassol, Francesca ^c   Candi, Eleonora ^c   Melino, Gerry ^c,d   Green, Douglas R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b INSERM   (France)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Bim; T lymphocyte

Indexed keywords

BIM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN MDM2; PROTEIN P73; T LYMPHOCYTE RECEPTOR; APOPTOSIS REGULATORY PROTEIN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; DNA BINDING PROTEIN; MDM2 PROTEIN, MOUSE; MEMBRANE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; GENE ACTIVATION; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CYTOLOGY; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DNA-BINDING PROTEINS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NF-KAPPA B; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEINS;

EID: 78149271340     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1006163107     Document Type: Article

References (49)

1. Green DR, Droin N, Pinkoski M (2003) Activation-induced cell death in T cells. Immunol Rev 193:70-81.
2. Janssen EM, et al. (2005) CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434:88-93.
3. Sandalova E, Wei CH, Masucci MG, Levitsky V (2004) Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc Natl Acad Sci USA 101:3011-3016.
4. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF (2000) A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407:642-645.
5. Wan YY, DeGregori J (2003) The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression. Immunity 18:331-342.
6. Weil R, Israël A (2006) Deciphering the pathway from the TCR to NF-kappaB. Cell Death Differ 13:826-833.
7. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27:693-733.
8. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM (1999) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321-325. (Pubitemid 129523450)
9. Li ZW, et al. (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189:1839-1845.
10. Senftleben U, Li ZW, Baud V, Karin M (2001) IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity 14:217-230. (Pubitemid 32289287)
11. Schmidt-Supprian M, et al. (2004) I kappa B kinase 2 deficiency in T cells leads to defects in priming, B cell help, germinal center reactions, and homeostatic expansion. J Immunol 173:1612-1619. (Pubitemid 38971591)
12. Schmidt-Supprian M, et al. (2003) Mature T cells depend on signaling through the IKK complex. Immunity 19:377-389. (Pubitemid 37153414)
13. Zheng Y, Vig M, Lyons J, Van Parijs L, Beg AA (2003) Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J Exp Med 197:861-874.
14. Levrero M, et al. (2000) The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J Cell Sci 113:1661-1670. (Pubitemid 30333115)
15. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
16. Zeng X, et al. (1999) MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol 19:3257-3266.
17. Barak Y, Gottlieb E, Juven-Gershon T, Oren M (1994) Regulation of mdm2 expression by p53: Alternative promoters produce transcripts with nonidentical translation potential. Genes Dev 8:1739-1749.
18. Jones SN, et al. (1996) Genomic organization of the mouse double minute 2 gene. Gene 175:209-213.
19. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I (2002) p53 stabilization is decreased upon NFkappaB activation: A role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 1:493-503.
20. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787-789.
21. Hoffmann A, Leung TH, Baltimore D (2003) Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J 22:5530-5539.
22. Sha WC, Liou HC, Tuomanen EI, Baltimore D (1995) Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321-330.
23. Weih F, et al. (1997) p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J Exp Med 185:1359-1370. (Pubitemid 27172916)
24. Edelstein LC, Lagos L, Simmons M, Tirumalai H, Gélinas C (2003) NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1. Mol Cell Biol 23:2749-2761. (Pubitemid 36403075)
25. Pan Y, Haines DS (1999) The pathway regulating MDM2 protein degradation can be altered in human leukemic cells. Cancer Res 59:2064-2067. (Pubitemid 29217665)
26. Green DR (2003) Death and NF-kappaB in T cell activation: Life at the edge. Mol Cell 11:551-552. (Pubitemid 36385110)
27. Chen Z, Knutson E, Wang S, Martinez LA, Albrecht T (2007) Stabilization of p53 in human cytomegalovirus-initiated cells is associated with sequestration of HDM2 and decreased p53 ubiquitination. J Biol Chem 282:29284-29295.
28. Bálint E, Bates S, Vousden KH (1999) Mdm2 binds p73 alpha without targeting degradation. Oncogene 18:3923-3929.
29. Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206-208.
30. Montes de Oca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
31. Fontemaggi G, et al. (2002) Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. J Biol Chem 277:43359-43368.
32. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683-694. (Pubitemid 32706359)
33. Sax JK, et al. (2002) BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 4:842-849.
34. Melino G, et al. (2004) p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279:8076-8083. (Pubitemid 38294697)
35. Ming L, et al. (2008) Sp1 and p73 activate PUMA following serum starvation. Carcinogenesis 29:1878-1884.
36. Ramadan S, et al. (2005) p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun 331:713-717. (Pubitemid 40615502)
37. Bouillet P, et al. (2002) BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415:922-926.
38. Hildeman DA, et al. (2002) Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16:759-767.
39. Zheng Y, et al. (2001) NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J Immunol 166:4949-4957.
40. O'Connor L, et al. (1998) Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17:384-395. (Pubitemid 28045479)
41. Möller C, et al. (2005) Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim. Blood 106:1330-1336. (Pubitemid 41129597)
42. Dejean AS, et al. (2009) Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat Immunol 10:504-513.
43. Toh WH, Nam SY, Sabapathy K (2009) An essential role for p73 in regulating mitotic cell death. Cell Death Differ 17:787-800.
44. Mendrysa SM, et al. (2003) mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. Mol Cell Biol 23:462-472.
45. Vater CA, Bartle LM, Dionne CA, Littlewood TD, Goldmacher VS (1996) Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts. Oncogene 13:739-748.
46. Parant J, et al. (2001) Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet 29:92-95. (Pubitemid 32801817)
47. Cianfrocca R, et al. (2008) RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells. Cell Death Differ 15:354-363.
48. Bouchier-Hayes L, Muñoz-Pinedo C, Connell S, Green DR (2008) Measuring apoptosis at the single cell level. Methods 44:222-228. (Pubitemid 351296444)
49. Busuttil V, et al. (2002) Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector. Oncogene 21:3213-3224. (Pubitemid 34548092)